看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。* T& L H' |/ V, D
% N! n$ ~7 L* B8 C
, q6 r3 `2 |8 L4 s( T& ~; aCurrently available feasibility data for possible combination strategies. 3 {( f* f. @ q
————————————————————————————————
! G. G$ k+ Z& f0 P/ `Combination Feasibility according to preliminary data
+ J B9 D, G# ?- F/ ]——————————————————————————————————+ t/ j" ^; q: g! [5 }
Bevacizumab + sorafenib Yes, reduced dose 7 Q! o0 q- D0 u7 {. p8 d
Bevacizumab + sunitinib† No
0 X' L7 M: a0 \3 gBevacizumab + temsirolimus Yes * J" o2 s, A% t
Bevacizumab + everolimus Yes ) I7 _. ]0 }9 @* B
Sorafenib + sunitinib ?
0 ^* s2 P- m7 w1 I- ISorafenib + temsirolimus Yes, reduced dose
6 S: D9 w; F! O+ `, g1 ZSorafenib + everolimus Yes, reduced dose & g/ r5 u9 T) h$ K
Sunitinib + temsirolimus† No 2 H- X. I4 {) L& b' V0 n5 u! E
Sunitinib + everolimus ? ! s4 P! }& U& ]% B. [, b5 J8 c
Temsirolimus + everolimus ?
) U( b$ \3 E" o+ ?————————————————————7 \, D; {: M/ A" N' M3 B
†Led to US FDA warning.+ f& J" z7 c9 U0 I
?: As yet unattempted combination./ R4 n( |! D J- U: }9 v7 K8 O
|